Safety and Immunogenicity of a Replication-Defective Adenovirus Type 5 HIV Vaccine in Ad5-Seronegative Persons: A Randomized Clinical Trial (HVTN 054)

BACKGROUND: Individuals without prior immunity to a vaccine vector may be more sensitive to reactions following injection, but may also show optimal immune responses to vaccine antigens. To assess safety and maximal tolerated dose of an adenoviral vaccine vector in volunteers without prior immunity,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Peiperl, Laurence, Morgan, Cecilia, Moodie, Zoe, Li, Hongli, Russell, Nina, Graham, Barney S., Tomaras, Georgia D., De Rosa, Stephen C., McElrath, M. Juliana
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2010
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2965084/
https://ncbi.nlm.nih.gov/pubmed/21048953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0013579
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky